Alejandro Falcón
Impact in
-
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 8
- Lung Cancer Research Studies 8
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 3
-
- Advanced Breast Cancer Therapies 6
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Javier Salvador Bofill (3 shared papers)Manuel Ruíz-Borrego (2 shared papers)Sonia Molina‐Pinelo (2 shared papers)María Ángeles Castilla (2 shared papers)Marta Benavent (3 shared papers)Luis Paz‐Ares (7 shared papers)M.J. Flor (4 shared papers)Silvia Antolín (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (3 papers)Annals of Oncology (3 papers)Clinical & Translational Oncology (2 papers)Cancers (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Alejandro Falcón
25 papers receiving 134 citations
Peers
Comparison fields: 5 of 34
- Oncology 89
- Cancer Research 24
- Pulmonary and Respiratory Medicine 44
- Genetics 13
- Molecular Biology 54
Countries citing papers authored by Alejandro Falcón
This map shows the geographic impact of Alejandro Falcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Falcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Falcón more than expected).
Fields of papers citing papers by Alejandro Falcón
This network shows the impact of papers produced by Alejandro Falcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Falcón. The network helps show where Alejandro Falcón may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Falcón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 36 | |
| 2 | 2023 | 31 | |
| 3 | 2020 | 12 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2019 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2019 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2015 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2017 | 1 |
About Alejandro Falcón
Alejandro Falcón is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 29 papers that have together received 135 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (6 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (89 citations), Cancer Research (24 citations), Pulmonary and Respiratory Medicine (44 citations), Genetics (13 citations) and Molecular Biology (54 citations). Alejandro Falcón has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Javier Salvador Bofill, Manuel Ruíz-Borrego, Sonia Molina‐Pinelo, María Ángeles Castilla, Marta Benavent, Luis Paz‐Ares, M.J. Flor, Silvia Antolín, Álvaro Montaño and Juan Carlos Montero. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical & Translational Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.